176 related articles for article (PubMed ID: 8499339)
1. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.
Classen S; Possinger K; Pelka-Fleischer R; Wilmanns W
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):315-9. PubMed ID: 8499339
[TBL] [Abstract][Full Text] [Related]
2. Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D.
Dannecker C; Possinger K; Classen S
Ann Oncol; 1996 Apr; 7(4):391-5. PubMed ID: 8805931
[TBL] [Abstract][Full Text] [Related]
3. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
7. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
10. Endometrial contraception: modulation of molecular determinants of uterine receptivity.
Puri CP; Katkam RR; Sachdeva G; Patil V; Manjramkar DD; Kholkute SD
Steroids; 2000; 65(10-11):783-94. PubMed ID: 11108889
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
14. The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.
van den Berg HW; Lynch M; Martin JH
Eur J Cancer; 1993; 29A(12):1771-5. PubMed ID: 8398308
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers.
Borras M; Lacroix M; Legros N; Leclercq G
Cancer Lett; 1997 Nov; 120(1):23-30. PubMed ID: 9570382
[TBL] [Abstract][Full Text] [Related]
17. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
18. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
[TBL] [Abstract][Full Text] [Related]
20. Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Cancer; 1990 Mar; 65(6):1375-9. PubMed ID: 2137722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]